LDOS

Business profile & competitive position

Leidos Holdings, Inc. operates under the Technology sector in the Information Technology Services industry, but its business model is closer to a science, research and engineering company than a conventional IT reseller. Through Leidos, Inc., it provides digital and mission-focused solutions to U.S. government and commercial customers worldwide. The company reports through four segments: National Security & Digital (44% of fiscal 2025 revenue), Health & Civil (30%), Commercial & International (13%), and Defense Systems (13%). Deliverables range from IT modernization and cyber operations to AI-enabled mission software, managed health services, air traffic systems, energy infrastructure, security detection products, and advanced maritime, aerospace and land defense systems.

The financial footprint suggests a defensible, relationship-driven franchise. Approximately 87% of fiscal 2025 revenue came from U.S. government contracts, and roughly 53% of employees hold U.S. security clearances while 19% are military veterans. That clearance concentration creates a natural barrier to entry because qualified labor is scarce and cleared work cannot be moved offshore easily. Return on equity of 27.6% is well above the net margin of 7.9%, implying the company generates strong capital efficiency from its asset base and contract backlog rather than from inflated pricing power alone. Company-funded R&D was $187 million in fiscal 2025, or 1.1% of consolidated revenues — a modest figure relative to many commercial technology peers, which is consistent with a services-led model where customer-funded development dominates.

Financial posture

Leidos currently carries a market capitalization of $17.9 billion and trades at a P/E ratio of 13.2. That valuation sits below what one typically sees for high-growth commercial technology companies, and it largely reflects the contract-profile mix: government services provide stability but rarely command software-like revenue multiples. Net margin is 7.9% and ROE is 27.6%. The large spread between net margin and ROE points to efficient balance-sheet deployment and steady turnover rather than exceptional gross margins.

Beta is 0.55, meaning the stock has historically moved roughly half as much as the broad market during broad swings. That low volatility fits the profile of a government-contractor revenue base where nearly 90% of sales come from U.S. federal programs. At the same time, a P/E of 13.2 plus a 27.6% ROE positions the equity closer to a capital-return, value-style character than to speculative growth within the broader Technology sector. The current price of $142.25 is also trading well above the 50-day EMA of $123.71, with an RSI of 73.9, which technical watchers would consider near overbought territory.

Strategic priorities & outlook

Leidos's most recent 10-K filing outlines five strategic growth pillars: space and maritime; energy infrastructure; digital modernization and cyber; mission software; and managed health services. These pillars line up with the segment weighting — National Security & Digital and Health & Civil together accounted for 74% of fiscal 2025 revenue — so the stated priorities largely mirror where revenue already lives.

Four operational goals appear repeatedly in the filing. The first is to complete and integrate the acquisition of Entrust (KENE Parent, Inc.) and achieve the expected benefits. The second is to expand the commercial health and infrastructure businesses, moving beyond the dominant U.S. government footprint. The third is to execute the broader business plan and long-term management initiatives. The fourth is to respond rapidly to emerging technology trends, specifically artificial intelligence. AI appears as both an opportunity and a capability requirement across the portfolio, from mission software to cyber operations, though the company frames it as an enabling trend rather than a standalone revenue line.

Macro & geopolitical exposure

Because Leidos is classified as an Information Technology Services provider and derives 87% of revenue from the U.S. government, its macro exposures center on federal budget cycles, defense appropriations and procurement policy rather than consumer spending or advertising demand. Changes in administration priorities, continuing resolutions, or shifts in defense and health-care spending can alter contract timing and margins faster than the headline revenue mix suggests.

The defense systems, cyber, and national security businesses also carry geopolitical sensitivity: escalation or de-escalation in maritime and aerospace programs can swing funding priorities. Around 8% of revenue comes from non-U.S. entities, which creates modest currency and foreign regulatory exposure, particularly if commercial energy infrastructure or international detection products grow. Supply-chain pressures matter for advanced hardware programs, and regulatory compliance costs are meaningful across health IT, air traffic systems and cleared defense work. Talent availability is another structural factor: demand for cleared engineers and veterans often outstrips supply, which can constrain growth in the highest-barrier segments.

Recent developments

The most recent catalyst cluster arrived in early August around the second-quarter 2026 report. On August 4, 2026, Seeking Alpha published the Q2 2026 earnings call transcript. The following day, both Zacks and MarketBeat published Q2 earnings call highlights, and Zacks followed on August 6 with an article titled "Here's Why Leidos (LDOS) is a Strong Growth Stock." The Zacks recap specifically called out defense growth amid a health reset, suggesting the headline story in the quarter was strength in defense-related segments partially offset by repositioning in the health and civil portfolio.

The August 4, 2026 report itself delivered actual EPS of $3.26 against an estimate of $2.91, an 11.9% surprise, continuing the company's long beat streak. Although the stock slipped 2.87% the next session, it recovered and then some, rising 7.88% over the following five trading days. That pattern — a beat followed by a brief sell-off and then a positive five-day drift — is worth watching because it repeats the broader post-earnings behavior the stock has shown across the trailing eight quarters.

Earnings behavior & post-earnings drift

Leidos has beaten earnings estimates in all of the last eight reported quarters, a 100% beat rate, with an average earnings surprise of 16%. The average five-day price move after those reports is +2.15%, and the drift direction is classified as "up." That said, the path is not straight. The stock has posted negative next-day reactions in several recent beats, including the most recent quarter.

Looking at the last four quarters, most recent first: on August 4, 2026, actual EPS was $3.26 versus the $2.91 estimate, a 12% surprise, and the stock fell 2.87% the next day but gained 7.88% over the next five sessions. On May 5, 2026, actual EPS of $3.13 beat the $2.90 estimate by 7.9%, yet the stock dropped 1.67% the next day and 6.41% over the next five days. On February 17, 2026, actual EPS of $2.76 beat the $2.61 estimate by 5.7%, driving a 6.19% next-day gain and a 7.8% five-day gain. And on November 4, 2025, actual EPS of $3.05 beat the $2.71 estimate by 12.5%, but the stock fell 2.25% the next day and 0.65% over the following five days. The next report is scheduled for November 3, 2026, before market open, with a consensus EPS estimate of $3.12.

For a deeper dive, readers may want to review the full institutional verdict on LDOS, including analyst rating distributions, target ranges, estimate revisions, and the latest factor-scored rankings across the Technology sector. That broader context can help round out any narrative built from earnings surprise patterns and 10-K strategic priorities.